Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Heartburn 1

Interventions

vocimagene amiretrorepvec 1enfortumab vedotin 1catumaxomab 1apatorsen 1Ty21a typhoid vaccine 1Therapeutics 1Photochemotherapy 1Paclitaxel 1Mitomycin 1Imiquimod 1Gemcitabine 1Flucytosine 1Ethacrynic Acid 1Bevacizumab 1BCG Vaccine 1Antibodies 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Non-Muscle Invasive Bladder Neoplasms × Ethacrynic Acid × Clear all
NCT02852564 2017-08-22

Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection

University of Kansas Medical Center

Phase 1 Completed
12 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Heartburn, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡